EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Multizentrische Studie

Evaluation of the Long-Term Tolerability and Clinical Benefit of Vorinostat in Patients With Advanced Cutaneous T-Cell Lymphoma

Madeleine Duvic, Elise A Olsen, Debra Breneman, Theresa R Pacheco, Sareeta Parker, Eric C Vonderheid, Rachel Abuav, Justin L Ricker, Syed Rizvi, Cong Chen, Kathleen Boileau, Alexandra Gunchenko und 2 weitere

Clinical Lymphoma and Myeloma · 2009-12 · 9 (6) · 412-416

DOI: 10.3816/clm.2009.n.082 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift Clinical Lymphoma and Myeloma, 2009-12. Verfasst von Madeleine Duvic und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The University of Texas M. D. Anderson Cancer Center, Box 1492, 1515 Holcombe Blvd, Houston, TX 77030, USA. mduvic@mdander…. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgedAntineoplastic AgentsFemaleHistone Deacetylase InhibitorsHumansHydroxamic AcidsLymphoma, T-Cell, CutaneousMaleMiddle AgedSkin NeoplasmsVorinostat

Substanzen

Antineoplastic AgentsHistone Deacetylase InhibitorsHydroxamic AcidsVorinostat

Autor:innen und Institutionen

  • Department of Dermatology, The University of Texas M. D. Anderson Cancer Center, Box 1492, 1515 Holcombe Blvd, Houston, TX 77030, USA. mduvic@mdanderson.org

Zitieren

APA

Duvic, M., Olsen, E. A., Breneman, D., Pacheco, T. R., Parker, S., Vonderheid, E. C., Abuav, R., Ricker, J. L., Rizvi, S., Chen, C., Boileau, K., Gunchenko, A., Sanz-Rodriguez, C., & Geskin, L. J. (2009). Evaluation of the Long-Term Tolerability and Clinical Benefit of Vorinostat in Patients With Advanced Cutaneous T-Cell Lymphoma. Clinical Lymphoma and Myeloma, 9(6), 412-416. https://doi.org/10.3816/clm.2009.n.082

Vancouver

Duvic M, Olsen EA, Breneman D, Pacheco TR, Parker S, Vonderheid EC, et al. Evaluation of the Long-Term Tolerability and Clinical Benefit of Vorinostat in Patients With Advanced Cutaneous T-Cell Lymphoma. Clinical Lymphoma and Myeloma. 2009;9(6):412-416. doi:10.3816/clm.2009.n.082

BibTeX
@article{Duvic2009,
  author = {Duvic, Madeleine and Olsen, Elise A and Breneman, Debra and Pacheco, Theresa R and Parker, Sareeta and Vonderheid, Eric C and Abuav, Rachel and Ricker, Justin L and Rizvi, Syed and Chen, Cong and Boileau, Kathleen and Gunchenko, Alexandra and Sanz-Rodriguez, Cesar and Geskin, Larisa J},
  title = {Evaluation of the Long-Term Tolerability and Clinical Benefit of Vorinostat in Patients With Advanced Cutaneous T-Cell Lymphoma},
  journal = {Clinical Lymphoma and Myeloma},
  year = {2009},
  volume = {9},
  number = {6},
  pages = {412--416},
  doi = {10.3816/clm.2009.n.082}
}
Kostenlos starten →